tiprankstipranks
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
Canadian Market
MDMA
PharmAla Biotech Holdings, Inc.
RESEARCH TOOLSreports
Want to see TSE:MDMA full AI Analyst Report?

PharmAla Biotech Holdings, Inc. (MDMA) Stock News & Sentiment

64 Followers
Cortexa Deepens Lead in Australia’s MDMA Market With New GMP Supply and Expanded Access
Premium
Company Announcements
Cortexa Deepens Lead in Australia’s MDMA Market With New GMP Supply and Expanded Access
2M ago
PharmAla Expands MDMA Trial Footprint With Nautilus Sanctuary Data Deal
Premium
Company Announcements
PharmAla Expands MDMA Trial Footprint With Nautilus Sanctuary Data Deal
3M ago
PharmAla Donates MDMA for Fibromyalgia Trial in Major U.S. Research Collaboration
Premium
Company Announcements
PharmAla Donates MDMA for Fibromyalgia Trial in Major U.S. Research Collaboration
3M ago
PharmAla Strikes Amsterdam UMC Supply Deal to Advance Commercial-Grade MDMA Packaging
Premium
Company Announcements
PharmAla Strikes Amsterdam UMC Supply Deal to Advance Commercial-Grade MDMA Packaging
3M ago
PharmAla Biotech Reshapes Board With Addition of Veteran Financial Executive
Premium
Company Announcements
PharmAla Biotech Reshapes Board With Addition of Veteran Financial Executive
3M ago
PharmAla Wins Østfold Hospital Trust Deal to Supply LaNeo MDMA for Depression Trial
Premium
Company Announcements
PharmAla Wins Østfold Hospital Trust Deal to Supply LaNeo MDMA for Depression Trial
4M ago
PharmAla Biotech Posts Rising Deposits as LaNeo MDMA Demand Builds and Australian Trial Plans Advance
Premium
Company Announcements
PharmAla Biotech Posts Rising Deposits as LaNeo MDMA Demand Builds and Australian Trial Plans Advance
5M ago
More TSE:MDMA News >

MDMA News on the Web

Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
TipRanks News
Neutral
Psychedelic: FDA awards Compass Pathways priority review voucher
TipRanks News
Bullish
PharmAla positioned to supply U.S. expanded access pathway for MDMA
TipRanks News
Bullish
Psychedelic: Compass Pathways, NRx Pharma report earnings results
TipRanks News
Bullish
Cortexa Deepens Lead in Australia’s MDMA Market With New GMP Supply and Expanded Access
TipRanks News
Neutral
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
TipRanks News
Bullish
PharmAla Expands MDMA Trial Footprint With Nautilus Sanctuary Data Deal
TipRanks News
Neutral
PharmAla signs supply, data agreement with Nautilus Sanctuary
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
TSE:MDMA
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:MDMA’s Media Buzz Sentiment?
1 articles about TSE:MDMA were published this week. In an average week, 0.5 articles are published.
    What is TSE:MDMA’s weekly average amount of articles?
    In an average week, 0.5 articles about TSE:MDMA are published.
      What is TSE:MDMA’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      DOCSDoximity
      AVAHAveanna Healthcare Holdings
      AQSTAquestive Therapeutics
      GOSSGossamer Bio
      HTFLHeartFlow, Inc.
      Showing the stocks with the most bullish news sentiment over the past week